-
Mashup Score: 13Pharmacometrics of high dose ivermectin in early COVID-19: an open label, randomized, controlled adaptive platform trial (PLATCOV) - 2 year(s) ago
Abstract Background: There is no generally accepted methodology for in vivo assessment of antiviral activity in SARS-CoV-2 infections. Ivermectin has been recommended widely as a treatment of COVID-19, but whether it has clinically significant antiviral activity in vivo is uncertain. Methods: In a multicentre open label, randomized, controlled adaptive platform trial, adult…
Source: eLifeCategories: General Medicine News, Latest HeadlinesTweet
-
Mashup Score: 28
A randomized, controlled trial (RCT) shows that even at a higher dose and longer treatment duration, the antimalarial drug ivermectin didn’t shorten the time to a sustained recovery from COVID-19. In the double-blind trial, published yesterday in JAMA, a team led by Duke University researchers evaluated time to sustained recovery among 1,206 COVID-19 patients at 93 US sites from Feb 16 to Jul…
Source: CIDRAPCategories: Infectious Disease, Latest HeadlinesTweet-
Higher ivermectin dose, longer duration still futile for #COVID19, trial finds The median time to sustained recovery was 11 days in both the #ivermectin and placebo group https://t.co/ip3TRgQWNg https://t.co/eTuuQ74stV
-
-
Mashup Score: 1Higher-Dose Ivermectin vs Placebo and Time to Sustained Recovery in Outpatients With COVID-19 - 2 year(s) ago
This platform randomized clinical trial examines the effectiveness ivermectin at a targeted dose of 600 μg/kg daily compared with placebo for the treatment of early mild to moderate COVID-19.
Source: jamanetwork.comCategories: Hem/Oncs, Latest HeadlinesTweet-
Kudos to the authors for asking this question…but at some point we need to start asking, collectively, whether it is ethical to continue to devote resources to #Ivermectin trials. https://t.co/VfUcaQXWIW
-
-
Mashup Score: 3Higher-Dose Ivermectin vs Placebo and Time to Sustained Recovery in Outpatients With COVID-19 - 2 year(s) ago
This platform randomized clinical trial examines the effectiveness ivermectin at a targeted dose of 600 μg/kg daily compared with placebo for the treatment of early mild to moderate COVID-19.
Source: jamanetwork.comCategories: General Medicine Journals and Societies, Latest HeadlinesTweet-
Among outpatients with mild to moderate COVID-19, treatment with ivermectin vs placebo did not improve time to sustained recovery. These findings do not support the use of #ivermectin in patients with mild to moderate #COVID19. https://t.co/F4ImpeD5Ov #CROI2023 https://t.co/0uNR9pozfR
-
-
Mashup Score: 7Colorado Doc Put on Probation for Ivermectin Prescriptions - 2 year(s) ago
Scott Rollins, MD, and the state medical board reached an agreement on ‘unprofessional conduct’
Source: www.medpagetoday.comCategories: General Medicine News, Latest HeadlinesTweet-
The Colorado Medical Board put a family medicine physician's license on probation after he admitted to prescribing #ivermectin for #COVID19 without properly informing patients of the drug's risks or discussing the FDA-approved treatments for the disease. https://t.co/CJsygidnl1
-
-
Mashup Score: 14Dispensing of Ivermectin From Veterans Administration Pharmacies During the COVID-19 Pandemic - 2 year(s) ago
This cohort study compares changes in ivermectin dispensing during the COVID-19 pandemic between the Veterans Administration (VA) and retail pharmacy settings and examines the association of the VA national formulary restriction with ivermectin dispensing.
Source: jamanetwork.comCategories: Healthcare Professionals, Latest HeadlinesTweet-
"....in contrast to retail pharmacies, #ivermectin dispensing in VA pharmacies increased minimally during the COVID-19 pandemic." "....findings highlight the ability of coverage restrictions to reduce the use of ineffective care." https://t.co/mvCbPuPurq via @JAMANetworkOpen
-
-
Mashup Score: 1Medical Board Takes Action Against Misinformation Doc - 2 year(s) ago
Pathologist Ryan Cole, MD, is facing discipline for negligence, spreading false statements
Source: www.medpagetoday.comCategories: General Medicine News, Latest HeadlinesTweet-
Ryan Cole, MD, is said to have made "numerous false and misleading statements" during public presentations on the pandemic, COVID vaccines, the use of #ivermectin to treat #COVID, and the effectiveness of masks, according to the @WAMedCommission: https://t.co/liFTGm8z7H https://t.co/b33GtSUggC
-
-
Mashup Score: 0Wolters Kluwer Health - 2 year(s) ago
JavaScript Error JavaScript has been disabled on your browser. You must enable it to continue. Here’s how to enable JavaScript in the following browsers: Internet Explorer From the Tools menu, select Options Click the Content tab Select Enable JavaScript Firefox From the Tools…
Source: lww.comCategories: Emergency Medicine, Latest HeadlinesTweet-
Our best-read column last year by the late James R. Roberts, MD: #Ivermectin had been touted as a #COVID19 treatment, but the evidence was clear: It just didn’t work. #CME #FOAMed https://t.co/invIF9Ysy3 #bestof2022 https://t.co/gUwJ3h1GIR
-
-
Mashup Score: 0A mixed methods study exploring requests for unproven COVID therapies such as ivermectin and healthcare distrust in the rural South - 2 year(s) ago
The COVID-19 pandemic has led to contentious discourse regarding unproven COVID-19 therapies (UCTs),(e.g. ivermectin). Despite recommendations against…
Source: www.sciencedirect.comCategories: Latest Headlines, PulmonologyTweet-
A mixed methods #study exploring requests for unproven #COVID #therapies such as #ivermectin and #healthcare distrust in the rural #South https://t.co/KWv2a5tIj4 https://t.co/FlhgQzDnR3
-
-
Mashup Score: 3MedinCell - Technology | Value innovation - 2 year(s) ago
MedinCell is a pharmaceutical company at premarketing stage that develops innovative long-acting injectable medicines in many therapeutic areas.
Source: MEDINCELLCategories: Cardiologists, Latest HeadlinesTweet-
SAIVE randomised, double-blind, placebo-controlled clinic study brings the total to 16 statistically significant studies showing #Ivermectin is highly effective at protecting people from becoming infected with #Covid. Why is this not being covered? https://t.co/qqg3zr24Z9…
-
Study supports evidence that #ivermectin is ineffective at treating COVID-19 @elife @elife https://t.co/57nXzvZYeF https://t.co/KYovytgwY3